The wearable biosensors market is segmented by technology, including optical, thermal, piezoelectric, and electrochemical sensors. Among these, electrochemical biosensors, which measure an electrical signal resulting from a specific biological reaction, hold a commanding market share and are projected to have the highest growth trajectory. Their dominance is rooted in their unparalleled combination of selectivity, sensitivity, and the cost-effective manufacturability required for mass-market wearable devices.

Electrochemical sensors work by converting a biochemical event, such as the oxidation of glucose by an enzyme, into a measurable electrical signal (current, voltage, or impedance). This transduction method is highly precise and requires only small sample volumes, making it ideal for non-invasive or minimally invasive wearables like Continuous Glucose Monitors (CGM) and certain sweat sensors. Furthermore, the manufacturing of these sensors can be easily miniaturized using screen-printing and microfabrication techniques, which reduces production costs and allows for their integration into small, flexible patches.

The core application driving the strength of this segment is the continuous monitoring of metabolic biomarkers. The estimated market share for the wearable electrochemical biosensors segment is projected to expand significantly by 2034, with a strong CAGR expected through the next decade. The robust commercial success of CGM devices, which are a major component of this segment, guarantees continued investment in electrochemical research and development, ensuring it remains the predominant product type in the market.

Innovation in electrochemical biosensing is focusing on expanding its utility beyond glucose. New research is targeting the reliable, continuous measurement of neurotransmitters, drugs, and hormones, offering non-invasive pharmacokinetic/pharmacodynamic monitoring. Furthermore, advances in electrode materials, utilizing nanomaterials like graphene and carbon nanotubes, are increasing sensor sensitivity and longevity, promising future wearables that can accurately detect disease-specific protein biomarkers from sweat or tears with clinical accuracy.